224 Users Online
Volumetric Infusion Pumps Market by Product (Peristaltic and Cassette/ Piston), Peristaltic products held a market share of around 56.2% in the global market.
The Global revenue from the Volumetric Infusion Pumps Market was approximately US$ 927.3 Million in 2022, with the global market expected to grow at a CAGR of 5.9% to reach a valuation of approximately US$ 1.7 Billion by the end of 2033.
| Attribute | Details |
|---|---|
| Market Size (2023) | US$ 982.6 Million |
| Projected Market Value (2033) | US$ 1.7 Billion |
| Global Market Growth Rate (2023 to 2033) | 5.9% CAGR |
| Market Share of Top 5 Countries (2022) | 59.2% |
As assessed by Persistence Market Research, peristaltic products held a market share of around 56.2% in the global market, in 2022. Overall, volumetric infusion pumps market sales account for around 7.1% of revenue share in the global infusion pump market, which was valued at around US$ 13 Billion in 2022.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The Global Volumetric Infusion Pumps market recorded a historic CAGR of 5.2% in the last 7 years from 2015 to 2022.
Parenteral nutrition, blood products, and other intravenous fluid products are delivered to patients using volumetric pumps in a safe and precise manner. Volumetric infusion pumps couples the intravenous fluid bag and the plastic tube that connects to the patient via the intravenous (IV) route.
With the aid of producing high and controlled pressure, volumetric pumps are crucial in the injection of measured amounts of fluid or medicine into the flow. Hospitals utilize them to improve the accuracy and efficiency of patient care and medication administration.
Companies are focused on manufacturing user-friendly volumetric to configure, tailor-made solutions, customized as individual pumps, small therapy units, or a complex infusion system. Certain companies, as a part of the strategy to capture larger market share, are launching technologically advanced pumps that can be monitored remotely, with larger drug libraries.
As an alternative to manual IV infusion pumps, Pentland Medical developed the sophisticated Monidrop IV Fluid Monitor and Remote Monitoring, which precisely tracks the rate of infusion and overall volume infused.
Trends in market expansion are being generated by improvements in product design, increased competition, and expanding local production. As technology advances, manufacturers are expected to increase the number of patients they treat and minimize errors that result from poor design, such as alarm mistakes and oversights caused by improper drug flow management.
These factors are set to advance the growth within the global market.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version“Technologically Advanced Smart Pumps with Dose-Error Reduction System for Patient Safety, and Wireless Technology”
When a patient is unable to take their drugs or when an intravenous route is more efficient, IV therapy is frequently utilized in hospitals. Treatments for severe infections, cancer, dehydration, gastrointestinal disorders, autoimmune disorders, and even diarrhea are a few examples. Further, they are required for the transit of medications whose efficacy has been compromised by stomach acid or other elements. IV fluids are used to deliver medications to the appropriate location. Instantaneous and controlled delivery of nourishment or medications is provided through volumetric pumps.
In chemotherapy, IV therapy is used in combination with analgesic medications to alleviate pain. IV chemotherapy has the potential to destroy rapidly growing cancer cells. According to the World Health Organization (WHO), there were 18,078,957 cancer patients and 9,555,027 death cases in 2019 out of a total population of 7,676,965,500. As per WHO, among cancer treatment services, about 72% of countries preferred chemotherapy globally in 2019, while around 95% of countries with high-income population group used chemotherapy in the same year.
Rapid technological advancements are expected to favor companies in developing more user-friendly and technologically advanced infusion systems to reduce medication errors and patient harm. Few of them investing in smart intravenous pumps include Becton Dickinson, Baxter International, Fresenius Kabi, Micrel Medical Devices, and Q-Core Medical.
Another example is vTitan's next generation Accuflow IBP-550 and Accuflow IBP-550 Syringe Infusion Pumps for critical care in hospitals and homes for reliable and safe drug infusion. These pumps are useful and appropriate device for patients undergoing heart surgery, chemotherapy, or taking pain medication for precise administration and monitoring.
Infusion pump manufacturers are gradually incorporating advanced technologies such as dose-error reduction system [DERS] and barcode-enabled point of care (BPOC) systems owing to development and better access to wireless technology.
Smart pumps with DERS plus BPOC can prevent drug delivery to the wrong patients and thus, protect patient safety. This is expected to be a major factor driving growth of the smart pump market.
“Errors Associated With Smart Infusion Pumps, and Lack of Skilled Manpower”
Due to design flaws, infusion pumps are among the medical devices that are frequently recalled. Software issues, alarm issues, broken components, poor user interface design (human factor concerns), battery failure, fire, charring, electric shocks, or sparks are some more errors connected with smart infusion pumps.
A 2020 study on human-based errors utilizing smart infusion pumps was published in the journal Drug Safety. The study found that 3-7% of nurse-administered dosages had errors because of poor design, leading to an annual rate of 4000 preventable injuries. For instance, choosing the incorrect drug library, programming mistakes that unintentionally add or deduct an extra digit, etc.
The majority of occurrences of unfavorable feedback for infusion pumps involve user errors. For instance, the United Kingdom based Medicines and Healthcare Products Regulatory Agency (MHRA) reported that user errors accounted for 21% of all infusion pump-related problems in the United Kingdom in 2013. The development of centralized equipment libraries should be taken into consideration as a more efficient method of handling devices in this regard, according to the United Kingdom National Health Service (NHS), which could also increase patient safety.
The use of infusion pumps varies, and there is currently a dearth of adequate documentation regarding their use and the availability of their drug libraries.
Standardization of equipment is crucial for several hospital departments, including paediatric, critical care, etc.
Sales Team
Client Partner
Why is the United States Market Booming?
“Technological Advancements, Rising Prevalence of Chronic Diseases, and Availability of Comprehensive Care”
Due to increased use of specialty infusion pumps for the treatment of chronic diseases, an ageing population with an increase in the prevalence of chronic diseases like diabetes, and the presence of numerous large hospitals in the nation, the U.S. accounts for approximately 35.7% of the global market in 2022.
Another aspect of the growth of the U.S. market is technological development in volumetric pumps. For instance, an American healthcare company named Baxter International was established in 1931 with the purpose of producing intravenous treatments for sale and became a leader in medical innovation during the 20th century. The Spectrum IQ pump is the only product available in the market with a dose or rate change warning facility, which is intended to prevent possibly erroneous or hazardous drug doses from reaching the patient.
Will the Germany Be a Lucrative Market over the Forecast Period?
“Government Initiatives and Rising Adoption of Infusion Pumps At-Home”
The German market held around 7.0% market share of the global market in 2022. The German infusion pump market is anticipated to lead the European infusion pump market due to the widespread use of various pharmaceuticals and biotechnology companies, while expanding government initiatives to strengthen healthcare infrastructure are anticipated to fuel regional market growth.
The growing geriatric population with gastrointestinal disorders, cancer, cardiovascular diseases, and popularity of infusion pumps in the home setting, as well as the growing number of key players, are factors forecasted to drive the German market.
How is China Emerging as a Prominent Market?
“High Disposable Incomes, Low Treatment Costs, Well-Developed Healthcare Infrastructure, and Rising Government Initiatives”
China held a market share of about 2.1% in the global market in 2022. China’s population is dense with an elevated burden of chronic diseases like cancer, cardiovascular illnesses, gastrointestinal diseases, and the demand for medication, hormone, or nutrition supply is high as a result.
In the years to come, there will probably be more opportunities for the market for volumetric infusion pumps to grow due to the rising use of customized infusion systems. For instance, the Chinese business Kellymed is constantly advancing volumetric infusion pumps through research and development. Global markets for the product include America, Australia, Barbados, Bangladesh, Ecuador, Europe, and Guinea. Due to its adherence to the management tenets of credit orientation, customer focus, high efficiency, and mature services, the company enjoys a positive reputation among both domestic and foreign customers, thus promoting market expansion.
Which Product is Driving Demand within the Global Market?
“Cost-Effectiveness and High Reliability”
Peristaltic products held about 56.2% share of the global market in 2022 because of its advantages.
Peristaltic pumps are frequently used for chemical injection, dosing applications, and viscous fluids without causing tube damage. Peristaltic pumps are less extensive and more reliable for high-volume applications; they are simple to install and maintain, and they provide continuous flow.
Peristaltic pumps are also suitable equipment for academic, diagnostic centers, research institutions, diagnostic labs, and pharmaceutical businesses in small volumes as well without need of excellent tuned controlling.
Which Application Propels Growth within the Global Market?
“Rapid Pain Relief with Volumetric Pumps”
Analgesia application held around 34.1% share of the global market in 2022.
Patients experiencing pain because of an acute exacerbation of chronic conditions such as cancer, surgery, or trauma can use an infusion pump to administer their own analgesia. Because of their effectiveness and ease of availability, opioids are commonly used in pumps.
In type of patient-controlled analgesia (PCA) for pain treatment the patient decides when to take pain medication without overdosing to avoid drug side effects. In some cases, PCA is better option for pain relief than calling for a nurse to administer pain medication. Patients can receive smaller doses of pain medication more frequently. This drives the segment to expand over the forecast period.
Which End User Promotes Traction within the Global Market?
“For regular delivery of fluids by skilled personnel is driving the market growth”
The Hospital segment held around 46.7% share of the global market in 2022.
VIPs are medical devices that have the ability to constantly provide highly precise fluid dosages at very slow to very fast rates. VIPs are frequently used to control the flow of whole blood, blood products, intravenous medications, and fluids to patients. VIPs typically deliver fluids on a regular basis. Hospitals typically employ VIPs to increase the accuracy and efficiency of patient care and medication administration. As a result, the hospital sector makes up a larger portion of the ventricular infusion pumps market.
The major players are placing key strategies into action to achieve business growth through the introduction of innovative products, the expansion of manufacturing facilities, or collaboration for wider geographical scope.
A few examples of products launched by the key players:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the volumetric infusion pumps market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Covered |
|
| Report Coverage |
|
| Customization & Pricing | Available upon Request |
Product:
Application:
End User:
Region:
The global market is valued at around 927.3 Million in 2022.
Sales of the market are set to witness growth at a CAGR of 5.9% and be valued at around US$ 1.7 Billion by 2033.
Demand for the global market increased at a 5.2% CAGR from 2015 – 2022.
The U.S., Germany, France, the U.K., and Russia account for most demand within the market, and were holding around 59.2% market share in 2022.
The U.S. accounts for around 35.7% share of the global market in 2022.
Europe accounts for around 33.0% share of the global market in 2022.
The China market held a share of about 2.1% in the global volumetric infusion pumps market in 2022.
The volumetric infusion pumps industry in Russia held around 4.7% market share in 2022.
B. Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical, Inc., Becton, Dickinson and Company, Smiths Medical, Woodley Equipment Company Ltd., Mindray Medical International Ltd., ADOX S.A, Sino-Hero (Shenzhen) Bio-Medical Electronics Co. Ltd., Guangzhou Huaxi Medical Science Technology Co. Ltd., ASCOR, Shenzhen Shenke Medical Instrument Technical Development Co. Ltd., Daiwaha corp. ltd., CONTEC MEDICAL SYSTEMS Co. Ltd., are some of the key players within the global market.
Peristaltic pumps hold a share of around 56.2% in the global market, in 2022.
